Antiandrogens as environmental endocrine disruptors.

Steroid hormone receptors control fundamental events in embryonic development and sex differentiation through their function as ligand-inducible transcription factors. The consequences of disrupting these processes can be especially profound during development due to the crucial role hormones play in controlling transient and irreversible developmental processes. Several environmental chemicals, including metabolites of the fungicide vinclozolin and the pesticide DDT, disrupt male reproductive development and function by inhibiting androgen receptor mediated events. A variety of in vitro and in vivo approaches have been used to determine the molecular basis of environmental antiandrogen toxicity. These chemicals commonly bind androgen receptor with moderate affinity and act as antagonists by inhibiting transcription of androgen dependent genes.

[1]  L. Paulozzi,et al.  Hypospadias Trends in Two US Surveillance Systems , 1997 .

[2]  R. Tyl,et al.  Endocrine Screening Methods Workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. , 1997, Reproductive toxicology.

[3]  F. George Androgen Metabolism in the Prostate of the Finasteride-Treated, Adult Rat: A Possible Explanation for the Differential Action of Testosterone and 5α-Dihydrotestosterone during Development of the Male Urogenital Tract. , 1997, Endocrinology.

[4]  E. Wilson,et al.  Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications , 1997, Journal of Molecular Medicine.

[5]  L. Gray,et al.  Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism. , 1997, Toxicology and applied pharmacology.

[6]  Rosalind,et al.  Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. , 1996, Environmental health perspectives.

[7]  J. McLachlan,et al.  Ecoestrogens and embryos—is there a scientific basis for concern? , 1996 .

[8]  L. Gray,et al.  Three-dimensional quantitative structure--activity relationships for androgen receptor ligands. , 1996, Toxicology and applied pharmacology.

[9]  L. Gray,et al.  Emerging issues: the effects of endocrine disrupters on reproductive development , 1996 .

[10]  E. Langley,et al.  Evidence for an Anti-parallel Orientation of the Ligand-activated Human Androgen Receptor Dimer (*) , 1995, The Journal of Biological Chemistry.

[11]  E. Mulder,et al.  Ligand-induced Conformational Alterations of the Androgen Receptor Analyzed by Limited Trypsinization , 1995, The Journal of Biological Chemistry.

[12]  R. Hites,et al.  Global distribution of persistent organochlorine compounds. , 1995, Science.

[13]  J. Wilson,et al.  Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias. , 1995, The Journal of clinical endocrinology and metabolism.

[14]  F. Schröder,et al.  Decreased immunoreactive androgen receptor levels are not the cause of isolated hypospadias. , 1995, British journal of urology.

[15]  E. Wilson,et al.  Androgen Receptor Antagonist versus Agonist Activities of the Fungicide Vinclozolin Relative to Hydroxyflutamide (*) , 1995, The Journal of Biological Chemistry.

[16]  L. Gray,et al.  Persistent DDT metabolite p,p'–DDE is a potent androgen receptor antagonist , 1995, Nature.

[17]  J. Auger,et al.  Debate about sperm count decline. , 1998, Environmental health perspectives.

[18]  F. S. French,et al.  Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. , 1995, Molecular endocrinology.

[19]  M. Beato,et al.  Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  N. Keiding,et al.  Changes in semen and the testis , 1994, BMJ.

[21]  L. Gray,et al.  Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rat. , 1994, Toxicology and applied pharmacology.

[22]  J. Wilson,et al.  The androgen receptor of the urogenital tract of the fetal rat is regulated by androgen , 1994, Molecular and Cellular Endocrinology.

[23]  A R Woodward,et al.  Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. , 1994, Environmental health perspectives.

[24]  L. Gray,et al.  Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. , 1994, Toxicology and applied pharmacology.

[25]  E. Mulder,et al.  Mechanism of antiandrogen action: Conformational changes of the receptor , 1994, Molecular and Cellular Endocrinology.

[26]  F. S. French,et al.  A complex response element in intron 1 of the androgen-regulated 20-kDa protein gene displays cell type-dependent androgen receptor specificity. , 1993, The Journal of biological chemistry.

[27]  D. Russell,et al.  Steroid 5α-Reductase 2 Deficiency , 1993 .

[28]  E. Wilson,et al.  Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains. , 1993, The Journal of biological chemistry.

[29]  E. Barrack,et al.  Sexually dimorphic expression of estrogen receptors, but not of androgen receptors in human fetal external genitalia. , 1993, The Journal of clinical endocrinology and metabolism.

[30]  N. Keiding,et al.  Evidence for increasing incidence of abnormalities of the human testis: a review. , 1993, Environmental health perspectives.

[31]  N Keiding,et al.  Evidence for decreasing quality of semen during past 50 years. , 1992, BMJ.

[32]  E. Vaughan,et al.  Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. , 1992, Endocrinology.

[33]  F. S. French,et al.  Response elements of the androgen-regulated C3 gene. , 1992, The Journal of biological chemistry.

[34]  E. Wilson,et al.  Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. , 1992, The Journal of biological chemistry.

[35]  H. Bouwman,et al.  Malaria control and levels of DDT in serum of two populations in Kwazulu. , 1991, Journal of toxicology and environmental health.

[36]  P. Becker,et al.  Factors affecting levels of DDT and metabolites in human breast milk from Kwazulu. , 1990, Journal of toxicology and environmental health.

[37]  E. Jensen,et al.  Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Gorski,et al.  Conformational transitions of the estrogen receptor monomer. Effects of estrogens, antiestrogen, and temperature. , 1986, The Journal of biological chemistry.

[39]  B C Gladen,et al.  Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethene (DDE) in human milk: effects of maternal factors and previous lactation. , 1986, American journal of public health.

[40]  B. McGillivray,et al.  Hypospadias in British Columbia. , 1985, American journal of medical genetics.

[41]  M. Spindler DDT: health aspects in relation to man and risk/benefit assessment based thereupon. , 1983, Residue reviews.

[42]  E. Bostofte,et al.  Has the fertility of Danish men declined through the years in terms of semen quality? A comparison of semen qualities between 1952 and 1972. , 1983, International journal of fertility.

[43]  B. Katzenellenbogen,et al.  Physical properties of estrogen receptor complexes in MCF-7 human breast cancer cells. Differences with anti-estrogen and estrogen. , 1982, The Journal of biological chemistry.

[44]  S. Leto,et al.  Changing parameters of donor semen. , 1981, Fertility and sterility.

[45]  C. Pfaffenberger,et al.  Determination of organochlorine pesticides and metabolites in drinking water, human blood serum, and adipose tissue. , 1981, Journal of toxicology and environmental health.

[46]  V. Adamović,et al.  Some observations concerning the ratio of the intake of organochlorine insecticides through food and amounts excreted in the milk of breast-feeding mothers , 1978, Bulletin of environmental contamination and toxicology.

[47]  L. Rosíval,et al.  Dynamics of benzene hexachloride (BHC) isomers and other chlorinated pesticides in the food chain and in human fat. , 1977, Ecotoxicology and environmental safety.

[48]  B. Henderson,et al.  Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. , 1976, Pediatrics.

[49]  F. S. French,et al.  Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. , 1976, The Journal of biological chemistry.

[50]  G. Ware Effects of DDT on reproduction in higher animals. , 1975, Residue reviews.

[51]  R. Bunge,et al.  Semen analysis: evidence for changing parameters of male fertility potential. , 1974, Fertility and sterility.

[52]  R. A. Sweet,et al.  Study of the incidence of hypospadias in Rochester, Minnesota, 1940-1970, and a case-control comparison of possible etiologic factors. , 1974, Mayo Clinic proceedings.

[53]  J. Gabica,et al.  Comparative organochlorine pesticide residues in serum and biopsied lipoid tissue: a survey of 200 persons in southern Idaho--1970. , 1972, Pesticides monitoring journal.

[54]  Jirăsek Je Genital ducts and external genitalia: development and anomalies. , 1971 .

[55]  J. Davies,et al.  Transplacental passage of pesticides. , 1970, American journal of obstetrics and gynecology.

[56]  R. Kimbrough,et al.  Chlorinated hydrocarbon insecticides in organs of stillborn and blood of newborn babies. , 1969, Archives of environmental health.